The U.S. Food and Drug Administration (FDA) has launched real-time Mammography Quality Standards Act (MQSA) reporting of adverse events at mammography facilities.
In the past, the FDA has posted a report on the Web twice per year on adverse actions taken against mammography facilities. Now, the agency plans to post actions taken against mammography facilities as soon as action has been taken.
The first event to be reported under the new practice occurred at Community Health Care in Davenport, IA. The facility terminated one of its mammography quality control (QC) technologists because it found that the technologist had falsified QC records. The FDA confirmed that this had happened and been reported to the state of Iowa; on November 29, that state's permit program suspended the technologist's x-ray permit for 180 days.
Related Reading
FDA: No. of mammo sites drops again, September 2, 2010
FDA releases new mammo standard, December 11, 2009
Number of U.S. mammo facilities drops, September 2, 2009
Report: Mammography market to continue growth, August 31, 2009
Mammography procedure volume drops 16% since 2000, March 17, 2009
Copyright © 2010 AuntMinnie.com
